CFA
TARO

Camarda Financial Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Camarda Financial Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,528
Closed -$819K – 295
2014
Q4 		$819K Buy
5,528
+2,254
+69% +$331K 0.52% 55
2014
Q3 		$504K Sell
3,274
-181
-5% -$27.3K 0.35% 48
2014
Q2 		$485K Sell
3,455
-844
-20% -$93.7K 0.33% 52
2014
Q1 		$477K Buy
+4,299
New +$468K 0.37% 58

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Camarda Financial Advisors's TARO Position: Q1 2015 in Review

Camarda Financial Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2015, closing a stake of 5,528 shares — an estimated $819K sold.

Camarda Financial Advisors first reported a position in TARO in Q1 2014 and held it in 4 quarters. The position peaked at $819K in Q4 2014. 96 funds tracked by Wall St. Rank hold TARO as of Q1 2015.

  • Camarda Financial Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2015 after selling out during the quarter.
  • Camarda Financial Advisors sold 5,528 Taro Pharmaceutical Industries Ltd. shares in Q1 2015, an estimated $819K.
  • Camarda Financial Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 4 quarters.
  • Camarda Financial Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $819K in Q4 2014.
  • 96 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2015.

Based on Camarda Financial Advisors's 13F filing for Q1 2015, filed 15 Apr 2015.